• linkedin
  • Increase Font
  • Sharebar

    Tomato-rich diet may lower prostate cancer risk

    Men who eat over 10 portions a week of tomatoes have an 18% lower risk of developing prostate cancer, according to a newly published study from the United Kingdom.

    J. Brantley Thrasher, MD, a Urology Times editorial consultant, called the research “thought provoking,” but not a game changer.


    Related - Study: Androgen inhibitor reduces death risk by 27%

    To assess if following dietary and lifestyle recommendations reduces risk of prostate cancer, researchers at the Universities of Bristol, Cambridge, and Oxford examined the diets and lifestyle of 1,806 men between the ages of 50 and 69 years with prostate cancer and compared them with 12,005 cancer-free men.

    The study, published online in Cancer Epidemiology, Biomarkers and Prevention (July 13, 2014), is the first study of its kind to develop a prostate cancer dietary index consisting of dietary components—selenium, calcium, and foods rich in lycopene—that have been linked to prostate cancer.

    Men who had optimal intake of these three dietary components had a lower risk of prostate cancer, researchers found.

    Tomatoes and tomato products, such as tomato juice and baked beans, were shown to be most beneficial, with an 18% reduction in risk found in men eating over 10 portions a week. This is thought to be due to lycopene, an antioxidant that fights off toxins that can cause DNA and cell damage.

    “Our findings suggest that tomatoes may be important in prostate cancer prevention,” said lead author Vanessa Er, PhD, of the School of Social and Community Medicine at the University of Bristol. “However, further studies need to be conducted to confirm our findings, especially through human trials. Men should still eat a wide variety of fruits and vegetables, maintain a healthy weight, and stay active.”


    Next: Researchers examine World Cancer Research Fund and American Institute for Cancer Research recommendations


    More on Prostate Cancer

    Surgery up, brachytherapy down for localized PCa

    Prostate cancer screening still common in older men

    ERSPC: PSA screening cuts PCa deaths by one-fifth


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results